Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System

Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System

Tumors of the digestive system, when combined together, account for more new cases and deaths per year than tumors arising in any other system of the body and their incidence continues to increase. Despite major efforts aimed at discovering and validating novel and effective drugs against these mali...

Full description

Bibliographic Details
Main Authors:	Federica Laudisi, Martin Marônek, Antonio Di Grazia, Giovanni Monteleone, Carmine Stolfi
Format:	Article
Language:	English
Published:	MDPI AG 2020-07-01
Series:	International Journal of Molecular Sciences
Subjects:	drug repurposing colorectal cancer hepatocellular carcinoma chemotherapy benzimidazole salicylanilide
Online Access:	https://www.mdpi.com/1422-0067/21/14/4957

Similar Items

The pharmacology of halogenated salicylanilides and their anthelmintic use in animals : review article
by: G.E. Swan
Published: (1999-07-01)

Niclosamide Is Active In Vitro against Mycetoma Pathogens
by: Abdelhalim B. Mahmoud, et al.
Published: (2021-06-01)

Screening of Benzimidazole-Based Anthelmintics and their Enantiomers as Repurposed Drug Candidates in Cancer Therapy
by: Rosalba Florio, et al.
Published: (2021-04-01)

Rafoxanide Induces Immunogenic Death of Colorectal Cancer Cells
by: Antonio Di Grazia, et al.
Published: (2020-05-01)

Viruses in Cancers of the Digestive System: Active Contributors or Idle Bystanders?
by: Martin Marônek, et al.
Published: (2020-10-01)

Transcriptomics-Based Drug Repurposing Approach Identifies Novel Drugs against Sorafenib-Resistant Hepatocellular Carcinoma
by: Kelly Regan-Fendt, et al.
Published: (2020-09-01)

Harmful Use of Veterinary Drugs: Blindness Following Closantel Poisoning in a 5-Year-Old Girl
by: Laila Essabar, et al.
Published: (2014-12-01)

Antimycobacterial Assessment of Salicylanilide Benzoates including Multidrug-Resistant Tuberculosis Strains
by: Jiřina Stolaříková, et al.
Published: (2012-10-01)

Beyond TNBC: Repositioning of Clofazimine Against a Broad Range of Wnt-Dependent Cancers
by: Jiabin Xu, et al.
Published: (2020-12-01)

Repositioning of Antiparasitic Drugs for Tumor Treatment
by: Yan-Qi Li, et al.
Published: (2021-04-01)

Molluscicidal activity and mechanism of toxicity of a novel salicylanilide ester derivative against Biomphalaria species
by: Ping He, et al.
Published: (2017-08-01)

Theoretical study of the geometric and electronic characterization of carbendazim-based drug (Nocodazole)
by: Muhammad Khattab
Published: (2020-06-01)

Role of MicroRNAs-221/222 in Digestive Systems
by: Juntaro Matsuzaki, et al.
Published: (2015-08-01)

Benzimidazoles Downregulate Mdm2 and MdmX and Activate p53 in MdmX Overexpressing Tumor Cells
by: Zuzana Mrkvová, et al.
Published: (2019-06-01)

Antimycobacterial Activity of Salicylanilide Benzenesulfonates
by: Jiřina Stolaříková, et al.
Published: (2012-01-01)

Novel Cholinesterase Inhibitors Based on O-Aromatic N,N-Disubstituted Carbamates and Thiocarbamates
by: Martin Krátký, et al.
Published: (2016-02-01)

Relative bioavailability of rafoxanide following intraruminal and intra-abomasal administration in sheep
by: G.E. Swan, et al.
Published: (1999-07-01)

Antiproliferative and Pro-Apoptotic Effect of Novel Nitro-Substituted Hydroxynaphthanilides on Human Cancer Cell Lines
by: Tereza Kauerova, et al.
Published: (2016-07-01)

Challenges and Opportunities for Drug Repositioning in Fibrodysplasia Ossificans Progressiva
by: Francesc Ventura, et al.
Published: (2021-02-01)

The Dual Role of Smad7 in the Control of Cancer Growth and Metastasis
by: Carmine Stolfi, et al.
Published: (2013-12-01)

Antifungal Activity of Salicylanilides and Their Esters with 4-(Trifluoromethyl)benzoic Acid
by: Martin Krátký, et al.
Published: (2012-08-01)

Turning genome-wide association study findings into opportunities for drug repositioning
by: Alexandria Lau, et al.
Published: (2020-01-01)

The assessment of efficient representation of drug features using deep learning for drug repositioning
by: Mahroo Moridi, et al.
Published: (2019-11-01)

Drug Repositioning for Effective Prostate Cancer Treatment
by: Beste Turanli, et al.
Published: (2018-05-01)

Impact of Food Additives on Gut Homeostasis
by: Federica Laudisi, et al.
Published: (2019-10-01)

Ring-Substituted 1-Hydroxynaphthalene-2-Carboxanilides Inhibit Proliferation and Trigger Mitochondria-Mediated Apoptosis
by: Tereza Kauerová, et al.
Published: (2020-05-01)

Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies
by: Galun D, et al.
Published: (2017-07-01)

Clinical Perspective of FDA Approved Drugs With P-Glycoprotein Inhibition Activities for Potential Cancer Therapeutics
by: Jiun-I Lai, et al.
Published: (2020-11-01)

Identification of a Five-Gene Prognostic Model and Its Potential Drug Repurposing in Colorectal Cancer Based on TCGA, GTEx and GEO Databases
by: Feng Yang, et al.
Published: (2021-01-01)

Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
by: Daniele Parisi, et al.
Published: (2020-01-01)

Drug Repositioning in Glioblastoma: A Pathway Perspective
by: Sze Kiat Tan, et al.
Published: (2018-03-01)

First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis
by: Alessandro Ottaiano, et al.
Published: (2018-05-01)

On the importance of targeting parasite stem cells in anti-echinococcosis drug development
by: Brehm Klaus, et al.
Published: (2014-01-01)

Drug Repositioning Screen on a New Primary Cell Line Identifies Potent Therapeutics for Glioblastoma
by: Filiz Senbabaoglu, et al.
Published: (2020-12-01)

Changing Trends in Computational Drug Repositioning
by: Jaswanth K. Yella, et al.
Published: (2018-06-01)

New Approaches in Oncology for Repositioning Drugs: The Case of PDE5 Inhibitor Sildenafil
by: Marian Cruz-Burgos, et al.
Published: (2021-02-01)

Anthelmintic Flubendazole and Its Potential Use in Anticancer Therapy
by: Kristýna Čáňová, et al.
Published: (2017-06-01)

Multiple anthelmintic resistance at a goat farm in Slovakia
by: Babják M., et al.
Published: (2021-06-01)

Update in Systemic and Targeted Therapies in Gastrointestinal Oncology
by: Nelson S. Yee
Published: (2018-03-01)

Repositioning of Immunomodulators: A Ray of Hope for Alzheimer’s Disease?
by: Antonio Munafò, et al.
Published: (2020-12-01)